An update on occupation and prostate cancer

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 501-516

  Doolan, Glenn ^a   Benke, Geza ^a   Giles, Graham ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Maximum allowable concentrations; Occupational exposure; Prostate cancer; Risk; Risk factors; Threshold

Indexed keywords

HUMAN; MALE; OCCUPATIONAL EXPOSURE; PROSTATE TUMOR; REVIEW; RISK FACTOR;

HUMANS; MALE; OCCUPATIONAL EXPOSURE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84894654363     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.501     Document Type: Review

References (108)

1. Achanzar WE, Diwan BA, Liu J, et al (2001). Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res, 61, 455-8.
2. Achanzar WE, Webber MM, Waalkes MP (2002). Altered apoptotic gene expression and acquired apoptotic resistance in cadmium-transformed human prostate epithelial cells. Prostate, 52, 236-44.
3. Agalliu I, Eisen EA, Kriebel D, Quinn MM, Wegman DH (2005). A biological approach to characterizing exposure to metalworking fluids and risk of prostate cancer (United States). Cancer Causes Control, 16, 323-31.
4. Anetor JI, Ajose F, Anetor GO, et al (2008). High cadmium/zinc ratio in cigarette smokers: potential implications as a biomarker of risk of prostate cancer. Niger J Physiol Sci, 23, 41-9.
5. Aronson KJ, Wilson JW, Hamel M, et al (2010). Plasma organochlorine levels and prostate cancer risk. J Exposure Sci & Environ Epidemiol, 20, 434-45.
6. Atkinson WD, Law DV, Bromley KJ, et al (2007). A decline in mortality from prostate cancer in the uk atomic energy authority workforce. J Radiolog Protection, 27, 437-45.
7. Band PR, Abanto Z, Bert J, et al (2011). Prostate cancer risk and exposure to pesticides in British Columbia farmers. Prostate, 71, 168-83.
8. Barry KH, Koutros S, Andreotti G, et al (2012). Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk. Carcinogenesis, 33, 331-7.
9. Barry KH, Koutros S, Berndt SI, et al (2011). Genetic variation in base excision repair pathway genes, pesticide exposure, and prostate cancer risk. Environ Health Perspect, 119, 1726-32.
10. Beall C, Bender TJ, Cheng H, et al (2005). Mortality among semiconductor and storage device-manufacturing workers. J Occup Environ Med, 47, 996-1014.
11. Benbrahim-Tallaa L. Waalkes MP (2008). Inorganic arsenic and human prostate cancer. Environ Health Perspect, 116, 158-64.
12. Bodiwala D, Luscombe CJ, French ME, et al (2003). Associations between prostate cancer susceptibility and parameters of exposure to ultraviolet radiation. Cancer Lett, 200, 141-8.
13. Bodiwala D, Luscombe CJ, Liu S, et al (2003). Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight. Cancer Lett, 192, 145-9.
14. Boers D, Zeegers MP, Swaen GM, et al (2005). The influence of occupational exposure to pesticides, polycyclic aromatic hydrocarbons, diesel exhaust, metal dust, metal fumes, and mineral oil on prostate cancer: a prospective cohort study. Occup Environ Med, 62, 531-7.
15. Bostwick DG, Burke HB, Djakiew D, et al (2004). Human prostate cancer risk factors. Cancer, 101, 2371-490.
16. Budnik LT, Kloth S, Velasco-Garrido, M Baur X (2012). Prostate cancer and toxicity from critical use exemptions of methyl bromide: environmental protection helps protect against human health risks. Environ Health, 11, 5.
17. Buja A, Lange JH, Perissinotto E, et al (2005). Cancer incidence among male military and civil pilots and flight attendants: an analysis on published data. Toxicol and Indus Health, 21, 273-82.
18. Burns C, Bodner K, Swaen G, et al (2011). Cancer incidence of 2,4-d production workers. International J of Environmental Res & Public Health, 8, 3579-90.
19. Charles LE, Loomis D, Shy C (2003). Electromagnetic fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers. Am J Epidemiol, 157, 683-91.
20. Christensen CH, Platz EA, Andreotti G, et al (2010). Coumaphos exposure and incident cancer among male participants in the agricultural health study (AHS). Environ Health Perspect, 118, 92-6.
21. Cockburn M, Mills P, Zhang X, et al (2011). Prostate cancer and ambient pesticide exposure in agriculturally intensive areas in California. Am J Epidemiol, 173, 1280-8.
22. Crook JM, O'Callaghan CJ, Duncan G, et al (2012). Intermittent androgen suppression for rising PSA level after radiotherapy. New Engl J Med, 367, 895-903.
23. Cui JS, Staples MP, Hopper JL, et al (2001). Segregation analysis of 1,476 population-based Australian families affected by prostate cancer. Am J Human Genetics, 68, 1207-18.
24. De Vries E, Soerjomataram I, Houterman S, Louwman, MW, Coebergh JW (2007). Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation? Am J Epidemiol, 165, 966-72.
25. Delzell E, Brown DA, Matthews R (2003). Mortality among hourly motor vehicle manufacturing workers. J Occupational & Environmental Medicine, 45, 813-30.
26. Dennis LK, Dawson DV (2002). Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology, 13, 72-9.
27. Dombi GW, Rosbolt JP, Severson RK (2010). Neural network analysis of employment history as a risk factor for prostate cancer. Computers in Biology & Medicine, 40, 751-7.
28. Drasch G, Schopfer J. Schrauzer GN (2005). Selenium/Cadmium ratios in human prostates: indicators of prostate cancer risk of smokers and nonsmokers, and relevance to the cancer protective effects of selenium. Biol Trace Elem Res, 103, 103-7.
29. Flinton DM, Walters NJ (2004). Occupational activity and risk of prostate cancer in ireland. J Radiotherapy in Practice, 4, 102-6.
30. Freedman DM, Dosemeci M, Mcglynn K (2002). Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med, 59, 257-62.
31. Friedenreich CM, Mcgregor SE, Courneya KS, Angyalfi SJ, Elliott FG (2004). Case-Control study of lifetime total physical activity and prostate cancer risk. Am J Epidemiol, 159, 740-9.
32. Fritschi L, Glass DC, Tabrizi JS, Leavy JE, Ambrosini GL (2007). Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia. Occupational and Environmental Med, 64, 60-5.
33. Gershkevitsh E, Hildebrandt G, Wolf U, et al (2002). Chromosomal aberration in peripheral lymphocytes and doses to the active bone marrow in radiotherapy of prostate cancer. Strahlentherapie und Onkologie, 178, 36-42.
34. Giles GG, Severi G, English DR, et al (2003). Early growth, adult body size and prostate cancer risk. Int J Cancer, 103, 241-5.
35. Giles GG, Severi G, Mccredie MR (2001). Smoking and prostate cancer: findings from an Australian case-control study. Ann Oncol, 12, 761-5.
36. Girschik J, Glass D, Ambrosini GL, Fritschi L (2010). Could mining be protective against prostate cancer? A study and literature review. Occupational & Environmental Med, 67, 365-74.
37. Goyer RA, Liu J, Waalkes MP (2004). Cadmium and cancer of prostate and testis. Biometals, 17, 555-8.
38. Gwini S, Macfarlane E, Del Monaco A, et al (2012). Cancer incidence, mortality, and blood lead levels among workers exposed to inorganic lead. Ann Epidemiol, 22, 270-6.
39. Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A (2004). Mortality from solid cancers among workers in formaldehyde industries]. Am J Epidemiol, 159, 1117-30.
40. Hessel PA, Kalmes R, Smith TJ (2004). A nested case-control study of prostate cancer and atrazine exposure. J Occup Environ Med, 46, 379-85.
41. Huff J, Lunn RM, Waalkes MP, Tomatis L, Infante PF (2007). Cadmium-induced cancers in animals and in humans. Int J Occupational & Environ Health, 13, 202-12.
42. IARC working group (2012). Arsenic, metals, fibres, and dusts. IARC monographs on the evaluation of carcinogenic risks to humans. IARC, 100, 11-465,.
43. Klaassen CD, Amdur MO, Doull J (1996). Casarett and Doull's Toxicology The Basic Science of Poisons, New York ; London, Mcgraw-Hill, Health Professions Division.
44. Koutros S, Alavanja MC, Lubin JH (2010). An update of cancer incidence in the agricultural health study. J Occupational & Environ Med, 52, 1098-105.
45. Koutros S, Beane Freeman E, Berndt SI, et al (2010). Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer. Cancer Res, 70, 9224-33.
46. Koutros S, Andreotti G, Berndt SI, et al (2011). Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer. Pharmacogenetics and Genomics, 21, 615-23.
47. Koyama H, Kitoh H, Satoh M, Tohyama C (2002). Low dose exposure to cadmium and its health effects (1). Genotoxicity and carcinogenicity. Nippon Eiseigaku Zasshi, 57, 547-55.
48. Krishnadasan A, Kennedy N, Zhao Y, Morgenstern H, Ritz B (2007). Nested case-control study of occupational chemical exposures and prostate cancer in aerospace and radiation workers. Am J Industrial Med, 50, 383-90.
49. Kumar V, Yadav CS, Singh S (2010). Cyp 1a1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer. Chemosphere, 81, 464-8.
50. Lagiou A, Samoli E, Georgila C, et al (2008). Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia. Eur J Cancer Prev, 17, 336-9.
51. Lam TV, Agovino P, Niu X, Roche L (2007). Linkage study of cancer risk among lead-exposed workers in New Jersey. Sci Total Environ, 372, 455-62.
52. Landau-Ossondo M, Rabia N, Jos-Pelage J (2009). Why pesticides could be a common cause of prostate and breast cancers in the french caribbean island, martinique. An overview on key mechanisms of pesticide-induced cancer. Biomedicine & Pharmacotherapy, 63, 383-95.
53. Lee JD, Wu SM, Lu LY, Yang YT, Jeng SY (2009). Cadmium concentration and metallothionein expression in prostate cancer and benign prostatic hyperplasia of humans. J Formos Med Assoc, 108, 554-9.
54. Li Q, Nishijo M, Nakagawa H, et al (2011). Relationship between urinary cadmium and mortality in habitants of a cadmium-polluted area: a 22-year follow-up study in Japan. Chinese Med J, 124, 3504-9.
55. Lumey LH, Pittman B, Wynder EL (1998). Alcohol use and prostate cancer in U.S. Whites: no association in a confirmatory study. Prostate, 36, 250-5.
56. Lynch SM, Mahajan R, Beane Freeman LE, Hoppin JA, Alavanja MC (2009). Cancer incidence among pesticide applicators exposed to butylate in the agricultural health study (AHS). Environ Res, 109, 860-8.
57. Lynch SM, Rusiecki JA, Blair A (2006). Cancer incidence among pesticide applicators exposed to cyanazine in the Agricultural Health Study. Environ Health Perspect, 114, 1248-52.
58. Macfarlane E, Glass D, Fritschi L (2009). Is farm-related job title an adequate surrogate for pesticide exposure in occupational cancer epidemiology? Occupational & Environ Med, 66, 497-501.
59. Maclennan PA, Delzell E, Sathiakumar N (2002). Cancer incidence among triazine herbicide manufacturing workers. J Occup Environ Med, 44, 1048-58.
60. Mahajan R, Blair A, Lynch CF (2006a). Fonofos exposure and cancer incidence in the Agricultural Health Study. Environ Health Perspect, 114, 1838-42.
61. Mahajan R, Bonner MR, Hoppin JA, Alavanja MC (2006). Phorate exposure and incidence of cancer in the Agricultural Health Study. Environ Health Perspect, 114, 1205-9.
62. Mills PK, Yang R (2003). Prostate cancer risk in california farm workers. J Occup Environ Med, 45, 249-58.
63. Mink PJ, Adami HO, Trichopoulos D, Britton NL, Mandel JS (2008). Pesticides and prostate cancer: a review of epidemiologic studies with specific agricultural exposure information. Eur J Cancer Prev, 17, 97-110.
64. Moon SJ, Fryer AA, Strange RC (2005). Ultraviolet radiation, vitamin d and risk of prostate cancer and other diseases. Photochem Photobiol, 81, 1252-60.
65. Mullins JK, Loeb S (2012). Environmental exposures and prostate cancer. Urol Oncol, 30, 216-9.
66. Myles P, Evans S, Lophatananon A, et al (2008). Diagnostic radiation procedures and risk of prostate cancer. Br J Cancer, 98, 1852-6.
67. Nakamura K, Yasunaga Y, Ko D (2002). Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int J Oncol, 20, 543-7.
68. Ndong JR, Blanchet P, Multigner L (2009). Pesticides and prostate cancer: epidemiological data. Bull Cancer, 96, 171-80.
69. Orsini N, Bellocco R, Bottai M, et al (2009). A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer, 101, 1932-8.
70. Ott C, Huber S (2006). The clinical significance of cosmic radiation in aviation. Praxis, 95, 99-106.
71. Park ES, Moon K, Kim HN. Lee WJ, Jin YW (2010). Radiation exposure and cancer mortality among nuclear power plant workers: a meta-analysis. J Prev Med Public Health, 43, 185-92.
72. Platz EA, Helzlsouer K J, Hoffman SC, et al (2002). Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate, 52, 288-96.
73. Prince MM, Ruder AM, Hein MJ (2006). Mortality and exposure response among 14,458 electrical capacitor manufacturing workers exposed to Polychlorinated Biphenyls (PCBs). Environ Health Perspect, 114, 1508-14.
74. Prins GS (2008). Endocrine disruptors and prostate cancer risk. Endocrine-Related Cancer, 15, 649-56.
75. Pukkala E, Aspholm R, Auvinen A, et al (2002). Incidence of cancer among nordic airline pilots over five decades: occupational cohort study. BMJ, 325, 567.
76. Pukkala E, Martinsen JI, Lynge E, et al (2009). Occupation and cancer-follow-up of 15 million people in five nordic countries. Acta Oncologica, 48, 646-790.
77. Ruder AM, Ward EM, Dong M, Okun A, Davis-King K (2004). Mortality patterns among workers exposed to styrene in the reinforced plastic boatbuilding industry: an update. Am J Industrial Med, 45, 165-76.
78. Rusiecki JA, Hou L, Lee WJ, et al (2006). Cancer incidence among pesticide applicators exposed to metolachlor in the agricultural health study. Int J Cancer, 118, 3118-23.
79. Rybicki BA, Neslund-Dudas C, Nock NL, et al (2006). Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Cancer Detect Prev, 30, 412-22.
80. Sahmoun AE, Case LD, Jackson SA, Schwartz GG (2005). Cadmium and prostate cancer: a critical epidemiologic analysis. Cancer Investigation, 23, 256-63.
81. Sass-Kortsak AM, Purdham JT, Kreiger N, Darlington G, Lightfoot NE (2007). Occupational risk factors for prostate cancer. Am J Ind Med, 50, 568-76.
82. Sathiakumar N, Maclennan PA, Mandel J, Delzell E (2011). A review of epidemiologic studies of triazine herbicides and cancer. Critical Reviews In Toxicol, 41, 1-34.
83. Sawada N, Iwasaki M, Inoue M (2010). Plasma organochlorines and subsequent risk of prostate cancer in japanese men: a nested case-control study. Environ Health Perspect, 118, 659-65.
84. Schiefer H, Von Toggenburg F, Seelentag W, et al (2009). Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters. Strahlentherapie Und Onkologie, 185, 689-95.
85. Settimi L, Masina A, Andrion A, Axelson O (2003). Prostate cancer and exposure to pesticides in agricultural settings. Int J Cancer, 104, 458-61.
86. Sharma-Wagner S, Chokkalingam AP, Malker HS (2000). Occupation and prostate cancer risk in Sweden. J Occupational & Environ Med, 42, 517-25.
87. Siddiqui MK, Srivastava S, Mehrotra PK (2002). Environmental exposure to lead as a risk for prostate cancer. Biomed Environ Sci, 15, 298-305.
88. Singh BR, Singh BN, Khan W, Singh HB, Naqvi AH (2012). Ros-mediated apoptotic cell death in prostate cancer LNCaP cells induced by biosurfactant stabilized CdS quantum dots. Biomaterials, 33, 5753-67.
89. Soto AM, Sonnenschein C (2010). Environmental causes of cancer: endocrine disruptors as carcinogens. Nature Rev Endocrinology, 6, 363-70.
90. St-Hilaire S, Mannel S, Commendador A, et al (2010). Correlations between meteorological parameters and prostate cancer. Int J Health Geographics, 9, 19.
91. Strom SS, Yamamura Y, Flores-Sandoval FN, Pettaway CA, Lopez DS (2008). Prostate cancer in mexican-americans: identification of risk factors. Prostate, 68, 563-70.
92. Subahir MN, Shah SA, Zainuddin ZM (2009). Risk factors for prostate cancer in universiti kebangsaan malaysia medical centre: a case-control study. Asian Pac J Cancer Prev, 10, 1015-20.
93. Telisman S, Colak B, Pizent A, Jurasovic J, Cvitkovic P (2007). Reproductive toxicity of low-level lead exposure in men. Environ Res, 105, 256-66.
94. Thursfield V, Farrugia H (Eds.) (2011). Cancer in Victoria: Statistics & Trends 2010. Cancer Epidemiology Centre, Cancer Council Victoria.
95. Thursfield V, Farrugia H, Giles G (2011). Cancer in Victoria: Social Context 2010. Cancer Epidemiology Centre, Cancer Council Victoria.
96. Thursfield V, Farrugia H, Karahalios E, Giles G (2012). Cancer in Survival Victoria 2012: Estimates for Survival for 2006-2010 (and comparisons with earlier periods). Cancer Council Victoria, Melbourne.
97. Thursfield V, Farrugia H, Robertson P, Giles G (2010). Canstat: A digest of facts and figures on cancer. Cancer in Victoria 2008. Cancer Epidemiology Centre, Cancer Council Victoria.
98. Van Maele-Fabry G, Libotte V, Willems J, Lison D (2006). Review and meta-analysis of risk estimates for prostate cancer in pesticide manufacturing workers. Cancer Causes Control, 17, 353-73.
99. Van Wijngaarden E, Singer EA, Palapattu GS (2008). Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001-2002 National Health and Nutrition Examination Survey. Prostate, 68, 122-8.
100. Verougstraete V, Lison D, Hotz P (2003). Cadmium, lung and prostate cancer: a systematic review of recent epidemiological data. J Toxicol Environ Health B Crit Rev, 6, 227-55.
101. Vinceti M, Venturelli M, Sighinolfi C (2007). Case-control study of toenail cadmium and prostate cancer risk in Italy. Science of the Total Environment, 373, 77-81.
102. Waalkes MP (2003). Cadmium carcinogenesis. Mutat Res, 533, 107-20.
103. White A, Coker AL, Du XL, Eggleston KS, Williams M (2011). Racial/ethnic disparities in survival among men diagnosed with prostate cancer in texas. Cancer, 117, 1080-8.
104. Wong O, Raabe GK (2000). A critical review of cancer epidemiology in the petroleum industry, with a meta-analysis of a combined database of more than 350,000 workers. Regulatory Toxicol & Pharmacol, 32, 78-98.
105. Xu X, Dailey AB, Talbott EO, et al (2010). Associations of serum concentrations of organochlorine pesticides with breast cancer and prostate cancer in U.S. adults. Environ Health Perspect, 118, 60-6.
106. Yang CY, Chang CC, Chiu HF (2008). Does arsenic exposure increase the risk for prostate cancer? J Toxicol Environ Health A, 71, 1559-63.
107. Young E, Kreiger N, Purdham J, Sass-Kortsak A (2009). Prostate cancer and driving occupations: could whole body vibration play a role? Int Archives of Occupational & Environmental Health, 82, 551-6.
108. Zeegers MPA, Friesema IHM, Goldbohm RA, Van Den Brandt PA (2004). A prospective study of occupation and prostate cancer risk. J Occupational and Environ Med, 46, 271-9.